Posts Tagged ‘business strategy’

Year
Month
Category
Clear Filters
From Farsighted to Flailing as the Obesity Market Advances

From Farsighted to Flailing as the Obesity Market Advances

November 12, 2025

Consumer Trends, Health & Obesity, Health Policy

This is a perilous and exciting time for investing in obesity innovation as the market for treating this disease advances dramatically. On the side of excitement, we note that the David Wainer in the Wall Street Journal predicts that “obesity drugs are about to go mass market.” Perilous for Novo On the side of peril, […]

Read More
Glowing Dice, photograph by Dark Elf Dice

Novo Nordisk in Obesity: Risk, Reward, and Caution

June 6, 2025

Health & Obesity

The first shall be last and the last shall be first. Right now, it seems that Novo Nordisk, the pharmaceutical company that was first to commit and break through with a major advance in obesity is now falling behind Eli Lilly and Company. This is a story of risk, reward, and caution in the competition […]

Read More
Lars Fruergaard Jørgensen in Senate HELP Hearing

A Startling Transition in Leadership at Novo Nordisk

May 18, 2025

Consumer Trends, Health & Obesity

“Today, we salute you, Lars Fruergaard Jørgensen,” writes Dave Knapp on his widely-read substack commentary. After a startling transition in leadership at Novo Nordisk, Jørgensen is now the outgoing CEO. Jørgensen is the CEO who guided the successful launch of Ozempic and Wegovy. He made the company into one of the most valuable in Europe. […]

Read More
Still Life with Mussels and Shrimp

The Endless Misery of Endless Shrimp: Why?

June 16, 2024

Consumer Trends, Food Industry, Health & Obesity

All-you-can-eat is a trap. In repeated case studies, it drives restaurants to lose money, sometimes to the point of bankruptcy. The latest poster child is Red Lobster and its Endless Shrimp deal that brought the chain financial misery and a Chapter 11 bankruptcy filing. How did this happen? Why did management seemingly have no clue […]

Read More
Potentialities of Television

WeightWatchers Adds Telehealth & Obesity Meds

March 7, 2023

Consumer Trends, Health & Obesity

Okay, we’re awake now. WeightWatchers has entered a deal to add telehealth and obesity meds to their business strategy. The company will spend $132 million in cash and stock to acquire Sequence – a subscription telehealth service for weight loss that utilizes advanced obesity meds like semaglutide. Weight Watchers CEO Sima Sistani explains her rationale […]

Read More
Eli Lilly and Company Headquarters

Is Success in Diabetes Possible Without Obesity Care?

May 4, 2019

Health & Obesity

My, how things have changed. Barely more than a decade ago, the dominant drugs for type 2 diabetes caused weight gain. Most big pharma companies were cutting obesity research. Eli Lilly and Sanofi were riding high in diabetes care and turning up their noses at obesity. But now the tables have turned. Sanofi’s diabetes business […]

Read More
Feeling Weightless

Weight Watchers Is Losing Weight (From Its Name)

September 25, 2018

Consumer Trends, Health & Obesity

Weight Watchers has just performed a neat trick. It lost a ton of dead weight and gained 4.5 percent on its stock price. All in one day. Henceforth, the company formerly known as Weight Watchers shall be simply WW. Wellness that Works.™ A Long Time Coming The handwriting has been on the wall for years […]

Read More

©2009-2026 ConscienHealth. All rights reserved. | Website Design by Mariela Antunes | Hosting by DTS